Skip to content

Efficacy and mechanism of tDCS combined with finger brain training to improve cognitive function in schizophrenia

Efficacy and mechanism of tDCS combined with finger brain training to improve cognitive function in schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092557
Enrollment
Unknown
Registered
2024-11-19
Start date
2024-11-22
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia patients with cognitive impairment

Interventions

tDCS+HE group:tDCS+Health Education
sham-tDCS+FBT group:sham-tDCS+Finger brain training
tDCS+FBT group:tDCS+Finger brain training

Sponsors

Beijing HuiLongGuan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Comply with the Diagnostic Criteria for Mental Disorders Diagnostic Statistics Manual (DSM-IV) for schizophrenia. 2.Aged 18-45 Years, received more than 5 years of formal education. 3.PANSS positive amount form item score <5 points, positive scale total score <22 points. 4.The condition is relatively stable, and there is no need to adjust the type and dosage of medication for the past 4 weeks or the estimated next 8 weeks. 5.The existence of cognitive damage: the number down Back breadth = <6. 6.right hand, using the Edinburgh hand evaluation scale to determine..

Exclusion criteria

Exclusion criteria: 1.Patients with combined mental retardation or organic mental disorders. 2.Merge clear central nervous system diseases or unstable physical diseases. 3.Impulsive excitement without cooperation or accompanied by severe depression, anxiety, and substance abuse. 4.Having limb disabilities or serious side effects, unable to perform finger brain training. 5.Pregnant or lactating women. 6.There are contraindications for magnetic resonance imaging scanning. 7.Has undergone non convulsive electroconvulsive therapy or transcranial magnetic stimulation therapy within the past 3 months.

Design outcomes

Primary

MeasureTime frame
Cognitive Function;

Secondary

MeasureTime frame
Social function and daily living ability;Morphological and functional plasticity parameters of gray matter and white matter;Clinical symptoms;

Countries

China

Contacts

Public ContactJiaqi Song

Beijing HuiLongGuan Hospital

350800271@qq.com+86 10 83024346

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026